Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0015 USD | -40.00% | -40.00% | -82.76% |
2023 | Endonovo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
2023 | Endonovo Therapeutics, Inc 's Sofpulse® Secures Taiwan FDA Approval | CI |
Chart calendar Endonovo Therapeutics, Inc.
Upcoming events on Endonovo Therapeutics, Inc.
Past events on Endonovo Therapeutics, Inc.
21/08/2023 | Q2 2023 Earnings Release |
10/03/2023 03:00 am | Shareholders Meeting |
21/11/2022 | Q3 2022 Earnings Release |
21/08/2020 12:21 am | Interim 2020 Earnings Release |
15/06/2020 05:30 pm | Q1 2020 Earnings Release |
04/05/2020 05:45 pm | FY 2019 Earnings Release |
13/08/2019 11:09 pm | Interim 2019 Earnings Release |
02/06/2016 | Marcum Microcap Conference |
Annual results
Fiscal Period | December | 2018 |
---|---|---|
Net sales Million USD | Released Forecast Spread | 0,08 |
EBITDA | Released Forecast Spread | 0,00 |
EBIT | Released Forecast Spread | 0,00 |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 |
Net income | Released Forecast Spread | 0,00 |
EPS USD | Released Forecast Spread | -20,0 |
Announcement Date | 15/04/19 |
Past sector events for Endonovo Therapeutics, Inc.
11/05/2024 01:32 am | CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release |
10/05/2024 05:56 pm | ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
10/05/2024 05:30 pm | PRIME MEDICINE, INC.: Q1 2024 Earnings Release |
10/05/2024 04:30 pm | AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
10/05/2024 05:35 am | SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
10/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
10/05/2024 01:45 am | ANAPTYSBIO, INC.: Q1 2024 Earnings Release |
10/05/2024 01:40 am | ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
10/05/2024 01:39 am | XENCOR, INC.: Q1 2024 Earnings Release |
10/05/2024 01:35 am | STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- ENDV Stock
- Calendar Endonovo Therapeutics, Inc.